Please login to the form below

Not currently logged in
Email:
Password:

Prosena Therapeutics

This page shows the latest Prosena Therapeutics news and features for those working in and with pharma, biotech and healthcare.

GSK's muscular dystrophy drug 'a breakthrough' says FDA

GSK's muscular dystrophy drug 'a breakthrough' says FDA

Holland-based Prosensa and GSK are currently in a race with Sarepta Therapeutics of the US (formerly AVI BioPharma) to bring an exon 51-skipping drug for DMD to market, and

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Larry Bell joins Dutch biopharma Prosensa Larry Bell joins Dutch biopharma Prosensa

    Dutch biopharmaceutical company Prosensa Therapeutics has appointed Larry Bell as head of global regulatory affairs. ... For his new role at Prosensa, which focuses on RNA-modulating therapeutics for rare diseases with high unmet need, Bell will be based

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics